What is he best known for?
The fields of study he is best known for:
Jack S. Richards mainly investigates Plasmodium falciparum, Immunology, Virology, Antibody and Immunity.
In most of his Plasmodium falciparum studies, his work intersects topics such as Antigen.
His Antigen study incorporates themes from Malaria vaccine and Parasitemia.
His specific area of interest is Immunology, where he studies Malaria.
His work carried out in the field of Virology brings together such families of science as Receptor, Binding site and Cell biology.
His research in Antibody is mostly focused on Immunoglobulin G.
His most cited work include:
- The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis (266 citations)
- The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis (266 citations)
- Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development (208 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Plasmodium falciparum, Malaria, Virology, Antigen and Immunology.
His Plasmodium falciparum research includes elements of Molecular biology and Immune system.
His study in the field of Parasitemia and Plasmodium vivax also crosses realms of Psychological intervention and Environmental protection.
In his research on the topic of Virology, Antigenic variation is strongly related with Haplotype.
Jack S. Richards has researched Antigen in several fields, including Antibody, Malaria vaccine and Recombinant DNA.
He focuses mostly in the field of Immunology, narrowing it down to matters related to Pregnancy and, in some cases, Chloroquine.
He most often published in these fields:
- Plasmodium falciparum (104.64%)
- Malaria (90.07%)
- Virology (88.08%)
What were the highlights of his more recent work (between 2017-2021)?
- Antigen (83.44%)
- Plasmodium falciparum (104.64%)
- Malaria (90.07%)
In recent papers he was focusing on the following fields of study:
Antigen, Plasmodium falciparum, Malaria, Virology and Malaria vaccine are his primary areas of study.
His studies in Antigen integrate themes in fields like Antibody and Plasmodium vivax.
His studies deal with areas such as Medical microbiology and Microbiology as well as Antibody.
The Diagnosis of malaria research he does as part of his general Plasmodium falciparum study is frequently linked to other disciplines of science, such as 3d print, therefore creating a link between diverse domains of science.
His research on Malaria frequently links to adjacent areas such as Immunity.
His Immunity research is under the purview of Immunology.
Between 2017 and 2021, his most popular works were:
- A portable microfluidic Aptamer-Tethered Enzyme Capture (APTEC) biosensor for malaria diagnosis. (51 citations)
- Targets of complement-fixing antibodies in protective immunity against malaria in children. (29 citations)
- Targets of complement-fixing antibodies in protective immunity against malaria in children. (29 citations)
In his most recent research, the most cited papers focused on:
Jack S. Richards mostly deals with Plasmodium falciparum, Malaria, Antigen, Diagnostic methods and Parasitemia.
Jack S. Richards combines subjects such as Acquired immune system, Microfluidic biosensor, Microfluidics, Vaccine trial and Monoclonal antibody with his study of Plasmodium falciparum.
His research in Malaria intersects with topics in Antibody, Vaccine evaluation and Immunity.
His Antigen study integrates concerns from other disciplines, such as Virology, Vaccination and Malaria vaccine.
His Diagnostic methods research includes a combination of various areas of study, such as Infrared spectroscopy, Beta-hematin, Computational biology and Molecular phenotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
